Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.
Append Medical has raised $4.3M in total funding. The most recent round was Series A. The last funding was announced in July 2023.
Append Medical's investors include Boston Scientific, MEDX Xelerator, Intellectual Ventures, ALIVE Israel HealthTech Fund, Shoni Health Ventures.
Append Medical is headquartered in Or Yehuda, Israel.
Append Medical develops a next-generation transcatheter Left Atrial Appendage (LAA) closure system.
Append Medical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Append Medical — Funding & Investors." VCBacked, July 6, 2023, https://www.vcbacked.co/company/append-medical. Accessed September 4, 2026.
VCBacked. (2023). Append Medical — Funding & Investors. Retrieved September 4, 2026, from https://www.vcbacked.co/company/append-medical
{{cite web |title=Append Medical — Funding & Investors |url=https://www.vcbacked.co/company/append-medical |website=VCBacked |access-date=September 4, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated